(Q39653344)

13 September 2017

1 reference

title

Surgery, recall antigens, immunity, and bacillus Calmette-Guerin vaccination (English)

1 reference

13 September 2017

Rosenthal SR

1

1 reference

PubMed ID

3293475

13 September 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

The American Journal of Surgery

13 September 2017

1 reference

13 September 2017

156

1 reference

13 September 2017

1

1 reference

13 September 2017

1-3

1 reference

The walk-in anergic patient. How best to assess the risk of sepsis following elective surgery

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Response to bcg vaccination and survival in advanced Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Role of delayed hypersensitivity in predicting postoperative morbidity and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Cellular kinetics associated with the development of acquired cellular resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

B.C.G. vaccination and leukaemia mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Results of administering B.C.G. to patients with melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Intralesional BCG in the treatment of metastatic malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

BCG immunotherapy of malignant melanoma: summary of a seven-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Clinical trials of immunotherapy. Present status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Impaired immunologic reactivity and recurrence following cancer surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

The role of cellular immunity in control of neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980158-2

10.1016/S0002-9610(88)80158-2

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

3293475